Cargando…
Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
BACKGROUND: Atrial fibrillation is the most common cardiac arrhythmia. It is responsible for up to 20% of all ischemic strokes. Rate control and anticoagulation are crucial for atrial fibrillation management and stroke prevention. CASE PRESENTATION: We present the case of an 84-year-old Italian woma...
Autores principales: | Scarano, Michele, Casale, Matteo, Mantini, Cesare, Imbalzano, Egidio, Consorti, Cristiana, Clemente, Daniela, Dattilo, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385244/ https://www.ncbi.nlm.nih.gov/pubmed/28390428 http://dx.doi.org/10.1186/s13256-017-1249-8 |
Ejemplares similares
-
Thrombophilia-Related Complications in the Treatment of a Left Atrial Appendage Thrombus: A Case Report
por: Parato, Vito Maurizio, et al.
Publicado: (2014) -
Successful Resolution of a Large Left Atrial and Left Atrial Appendage Thrombus with Rivaroxaban
por: Gaznabi, Safwan, et al.
Publicado: (2019) -
RIVAroxaban TWICE daily for lysis of thrombus in the left atrial appendage in patients with non-valvular atrial fibrillation: the RIVA-TWICE study
por: Piotrowski, Roman, et al.
Publicado: (2019) -
Risk of left atrial appendage thrombus in older patients with atrial fibrillation
por: Gawałko, Monika, et al.
Publicado: (2021) -
Resolution of a warfarin and dabigatran-resistant left atrial appendage thrombus with apixaban
por: Miwa, Yosuke, et al.
Publicado: (2016)